Get started
Author

Devi Prasad Sahoo

Observed names: Dr. Devi Prasad Sahoo, Prasad Sahoo, Devi, Sahoo, Devi Prasad
Observed institution: Indian Immunologicals (India)
ORCID: 0000-0003-1932-872X
Observed ORCID: 0000-0003-1932-872X
OpenAlex ID: A5088089340
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6–8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study
2019 · Sai Krishna Susarla, Madhu Gupta, et al. · Vaccine · 8
Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study
2021 · Sai Krishna Susarla, Sonali Palkar, et al. · Vaccine · 5
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
2023 · Sai Krishna Susarla, Madhu Gupta, et al. · Vaccine · 2
Longevity of humoral response in recipients of rabies pre-exposure prophylactic vaccination with Abhayrab®
2026 · Bhaskar Ganguly, Rajashakar Bellamcapu, et al. · Biologicals
A Phase II/III multicenter randomized single blind non-inferiority immunogenicity and safety study of TeddyVac™ vaccine of Human Biologicals Institute in healthy subjects of 10 years to 60 years of age
2024 · Sai Krishna Susarla, Manish Narang, et al. · Scandinavian Journal of Infectious Diseases
More Than a Decade and a Half of Serving the Cause of Control and Prevention of Rabies: a Review of Safety and Efficacy of Abhayrab - Purified Vero Cell Rabies Vaccine
2023 · Sahoo, Devi Prasad, Krishna, S. Sai · APCRI Journal
PDF
Ensuring Proper and Timely Prophylaxis Against Rabies; How Far Can We Bridge the Gaps
2023 · Prasad Sahoo, Devi, Krishna, S. Sai, et al. · APCRI Journal
PDF
Immunogenicity and safety of Mebella™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study
2023 · Sai Krishna Susarla, Rahul Jahagirdar, et al. · Vaccine
Works count: 10
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type